PostGlimpse

Dive Deep into Creativity: Discover, Share, Inspire

Investingvisualbriefing - Blog Posts

4 years ago
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News
Investing Visual Briefing 9/10/2020: Diffusion Pharma Update & Top Investing News

Investing Visual Briefing 9/10/2020: Diffusion Pharma update & top investing news


Tags
4 years ago
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News
Investing Visual Briefing 8/24/2020: Khiron Life Sciences Earnings & Top Investing News

Investing Visual Briefing 8/24/2020: Khiron Life Sciences earnings & top investing news


Tags
4 years ago
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News
Investing Visual Briefing 8/13/2020: Green Organic Dutchman Earnings & Top Investing News

Investing Visual Briefing 8/13/2020: Green Organic Dutchman earnings & top investing news


Tags
4 years ago
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News
Investing Visual Briefing 8/10/2020: FSD Pharma Earnings & Top Investing News

Investing Visual Briefing 8/10/2020: FSD Pharma earnings & top investing news


Tags
4 years ago
FSD Pharma Q2 2020 earnings: Received FDA approval to design clinical trial for COVID-19 treatment | Xanadu Investing
FSD Pharma released Q2 2020 earnings with key business updates related to its COVID-19 initiatives and other highlights.

Tags
4 years ago
Tilray Q2 2020 earnings preview: Consensus EPS -$0.40 and revenue $54.99M estimates | Xanadu Investing
Tilray is scheduled to announce Q2 2020 earnings after market close on Monday, August 10th. The consensus EPS estimate is -$0.40.

Tags
4 years ago
GW Pharmaceuticals Q2 2020 earnings: Epidiolex sales increase 64.6% | Xanadu Investing
GW Pharmaceuticals released earnings for its Q2 2020 that featured a 64.6% increase in Epidiolex sales to $117.7M.

Tags
4 years ago
CV Sciences Q2 2020 earnings: Store count up 37.8% over the past year | Xanadu Investing
CV Sciences announced its earnings for Q2 2020 with a 37.8% retail store count increase to 6,325 compared to 4,591 at the end of Q2 2019.

Tags
4 years ago
Greenlane Holdings Q2 2020 earnings: Vapor.com increased orders 74% to ~16,000 | Xanadu Investing
- Greenlane Holdings announced its Q2 2020 earnings with a 74% order increase to ~16,000 on its flagship DTC e-commerce platform, Vapor.com.

Tags
4 years ago
Investing Visual Briefing 8/7/2020: GW Pharmaceuticals earnings & top investing news | Xanadu Investing
Our Investing Visual Briefing showcases an infographic card deck to visualize recent events and information in the investing space.

Tags
4 years ago
Investing Visual Briefing 8/6/2020: Cronos earnings review & top investing news | Xanadu Investing
Our Investing Visual Briefing showcases an infographic card deck to visualize recent events and information in the investing spaces we currently cover. Our infographic cards are designed to maximize quick topic understanding and memorability.

Tags
4 years ago
Aldeyra Therapeutics Q2 2020 earnings: EPS of -$0.25 beats by $0.09 with favorable cash runway | Xanadu Investing
Aldeyra Therapeutics released its earnings for Q2 2020 with GAAP EPS of -$0.25 – a $0.09 beat of analyst consensus.

Tags
4 years ago
Silver One Resources announces exploration commencement on Nevada-based Cherokee Project | Xanadu Investing
Silver One Resources announced commencement of exploration on its wholly owned, Nevada-based Cherokee Project.

Tags
4 years ago
Heritage Cannabis to acquire CBD strategic access company Opticann | Xanadu Investing
Heritage Cannabis entered into an agreement to acquire all shares of Colorado-based CBD company Opticann for initial consideration of C$5M and earn-outs.

Tags
4 years ago
GW Pharmaceuticals Q2 2020 earnings preview: Consensus estimates of -$0.04 EPS and $124M revenue | Xanadu Investing
GW Pharmaceuticals is scheduled to announce Q2 earnings after market close on Thursday, August 6th. Its consensus estimates include -$0.04 EPS.

Tags
4 years ago
WeedMD entered an exclusive agreement with MM Technology Holdings, LLC – owner of Mary’s Brands and its Mary’s Medicinals product line.

Tags
4 years ago
Investing Visual Briefing 8/5/2020: Skeena Resources acquisition & top investing news | Xanadu Investing
Our Investing Visual Briefing showcases an infographic card deck to visualize recent events and information in the investing spaces we currently cover.

Tags
4 years ago
Skeena Resources acquires Eskay Creek project from Barrick Gold | Xanadu Investing
Skeena Resources (OTCQX: SKREF) exercised its option to acquire the British Columbia-based Eskay Creek project from Barrick Gold (NYSE: GOLD)(TSX: ABX).

Tags
4 years ago
Aphria expands to Israel via 2-year supply deal with Canndoc | Xanadu Investing
Aphria (NASDAQ: APHA) (TSX: APHA) entered a 2-year supply agreement with Canndoc to provide 3,000 kgs of bulk dried flower.

Tags
4 years ago
Auxly Cannabis closed $3M financing of unsecured convertible debentures | Xanadu Investing
Under the $25M unsecured convertible debenture standby facility Auxly Cannabis announced in April, the company announced the closing of an additional $3M.

Tags
4 years ago
Harvest One Cannabis sold Duncan, British Columbia-based facility for $8.2M | Xanadu Investing
Harvest One Cannabis entered an agreement to sell its Duncan, British Columbia-based cannabis cultivation and processing businesses for $8.2M in cash.

Tags
4 years ago
Investing Visual Briefing 8/7/2020: GW Pharmaceuticals Earnings & Top Investing News Https://bit.ly/IVB-8-7-2020

Investing Visual Briefing 8/7/2020: GW Pharmaceuticals earnings & top investing news https://bit.ly/IVB-8-7-2020 #investingvisualbriefing #cannabiscommunity #cannabis #medicalcannabis #marijuana #stocks #mmj #infographic #investing (at Toronto, Ontario)
https://www.instagram.com/p/CDl0dyJshKH/?igshid=2s7dy1yjyeiq


Tags
Loading...
End of content
No more pages to load
Explore Tumblr Blog
Search Through Tumblr Tags